GVK Biosciences, Asia’s leading contract research organization has opened its new clinical pharmacology unit (CPU) in Ahmedabad, India. The Ahmedabad CPU has 3 wards and 110 beds and will conduct studies in healthy volunteers.
With this unit, GVK BIO’s capacity increases upto 254 beds. (144 at Hyderabad and 110 at Ahmedabad). The Hyderabad unit has undergone international audits, inspections and has accreditations from the USFDA, DCG(I), ANVISA (Brazil), AFSSAPS (France), WHO and the Ministry of Health, Turkey.
